Compass Therapeutics, Inc. (CMPX)
NASDAQ: CMPX · Real-Time Price · USD
4.070
+0.170 (4.36%)
At close: Oct 9, 2025, 4:00 PM EDT
4.130
+0.060 (1.47%)
Pre-market: Oct 10, 2025, 5:43 AM EDT
Compass Therapeutics Market Cap
Compass Therapeutics has a market cap or net worth of $698.30 million as of October 10, 2025. Its market cap has increased by 196.80% in one year.
Market Cap
698.30M
Enterprise Value
607.26M
1-Year Change
196.80%
Ranking
Category
Stock Price
$4.07
Market Cap Chart
Since April 5, 2021, Compass Therapeutics's market cap has increased from $435.34M to $698.30M, an increase of 60.40%. That is a compound annual growth rate of 11.03%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 9, 2025 | 698.30M | 250.02% |
| Dec 31, 2024 | 199.50M | 0.34% |
| Dec 29, 2023 | 198.83M | -68.61% |
| Dec 30, 2022 | 633.47M | 105.02% |
| Dec 31, 2021 | 308.98M | -29.02% |
| Apr 5, 2021 | 435.34M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 757.36B |
| Johnson & Johnson | 454.91B |
| AbbVie | 411.31B |
| UnitedHealth Group | 329.36B |
| AstraZeneca | 266.44B |
| Novo Nordisk | 261.01B |
| Novartis AG | 255.35B |
| Abbott Laboratories | 231.52B |